Hereditary Angioedema and Heparin Therapy
Authors: ROBERT W. COLMAN
Journal: Annals of Internal Medicine (1976)

Comments1 September 1976Hereditary Angioedema and Heparin TherapyROBERT W. COLMAN, M.D., F.A.C.P.ROBERT W. COLMAN, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-85-3-399 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Doctors Frank, Gelfand, and Atkinson have presented an impressive NIH Conference on hereditary angioedema (Ann Intern Med 84:580-593, 1976). They indicate that although long-term and short-term prophylaxis of attacks have been successful, specific therapy for acute attacks is not available. Kininogen, the substrate of kallikrein, is activated and decreases during an attack, (1, 2), suggesting that bradykinin formation may play a role in the pathogenesis of this disease. The mode of release of the C2-kinin (3) released during attacks of hereditary angioedema is not fully known, but the inhibition of its formation by soybean trypsin inhibitor suggests...References References References1. LANDERMAN N, WEBSTER M, and BECKER E: Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy 33:330-341, 1962 CrossrefMedlineGoogle Scholar2. BURDON K, QUENG J, and THOMAS O: Observations on the biochemical abnormalities in hereditary angioneurotic edema. J Allergy 36:546-557, 1965 CrossrefMedlineGoogle Scholar3. DONALDSON V, RATNOFF O, DIAS D, and SILVA W: Permeability increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642-653, 1969 CrossrefMedlineGoogle Scholar4. ROSENBERG R: The coagulation fibrinolytic mechanism and the action of heparin. Adv Exp Med Biol 52:217-238, 1974 CrossrefGoogle Scholar5. LAHIRI B, BAGDASARIAN A, and MITCHELL B: Antithrombinheparin cofactor: an inhibitor of plasma kallikrein. Arch Biochem Biophys, 1976, in press CrossrefMedlineGoogle Scholar1. REIMANN H: Periodic Diseases. Philadelphia, F. A. Davis Co., 1963, p. 72 Google Scholar2. REIMANN H: Hereditary periodic edema, in The Interrelation of Familial Periodic Disorders. Am J Med Sci 243:727-739, 1962 CrossrefMedlineGoogle Scholar3. REIMANN H: Rhythms and periodicity in health and disease. Ann Clin Lab Sci 5:417-420, 1975 MedlineGoogle Scholar4. WOLF N: Introductory remarks, rhythmic functions in living systems. Ann NY Acad Sci 98:753, 1962 Google Scholar5. BAILEY R: Periodic hormonogenesis—a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 32:317-327, 1971 CrossrefMedlineGoogle Scholar6. CHAJEK T and ROMANOFF H: Cushing syndrome with cyclical edema and periodic secretion of corticosteroids. Arch Intern Med 136:441-446, 1976 CrossrefMedlineGoogle Scholar1. DONALDSON V, RATNOFF O, DIAS D, and SILVA E: Permeability increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642-653, 1969 CrossrefMedlineGoogle Scholar2. RENT R, ERTEL N, and EISENSTEIN R: Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. J Immunol 114:120-124, 1975 CrossrefMedlineGoogle Scholar3. DONALDSON V and EVANS R: A biochemical abnormality in hereditary angioneurotic edema. Am J Med 35:37-44, 1963 CrossrefMedlineGoogle Scholar4. OSLER W: Hereditary angioneurotic oedema. Am J Med Sci 95:362-367, 1888 CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ROBERT W. COLMAN, M.D., F.A.C.P.Affiliations: Hematology-Oncology Section Department of Medicine Hospital of the University of Pennsylvania Philadelphia, PA 19104 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDoes heparin prophylaxis prevent exacerbations of hereditary angioedema?Acquired C1 Esterase Inhibitor DeficiencySvetomir N. Markovic, MD, PhD, David J. Inwards, MD, Evangelos A. Frigas, MD, and Robert P. Phyliky, MDParallel Procoagulant and Anticoagulant Pathways for High Molecular Weight Kininogen Coagulant FunctionTraitement de l'œdème angioneurotique héréditaireKallikrein-Kinin System in Pathologic Conditions 1 September 1976Volume 85, Issue 3 Page: 399-400 Keywords Heparin Hereditary angioedema Pathogenesis Prophylaxis ePublished: 1 December 2008 Issue Published: 1 September 1976 PDF downloadLoading ...